Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Clinical Pathology 2009;62:1003-1008; doi:10.1136/jcp.2009.066944
Copyright © 2009 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

ORIGINAL ARTICLES

The clinicopathological significance of BUBR1 overexpression in hepatocellular carcinoma

A-W Liu1, J Cai1,2, X-L Zhao2, A-M Xu3, H-q Fu1, H Nian2, S-H Zhang2

1 Department of Oncology, The Second Affiliated Hospital, Nanchang University, Nanchang, PR China
2 Department of Pathology, Yueyang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, PR China
3 Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, PR China

Correspondence to:
Correspondence to Professor S-H Zhang, Department of Pathology, Yueyang Hospital, Shanghai University of Traditional Chinese Medicine, 110 Ganhe Road, Shanghai 200437, PR China; zhangshuhui100{at}sohu.com

Background and aims: BUBR1 is a key component of the mitotic spindle checkpoint, and its roles in human cancers are controversial and unclear. The aim of this study was to investigate the clinicopathological significance of BUBR1 expression in hepatocellular carcinoma (HCC).

Methods: The BUBR1 protein and its mRNA levels were measured in 58 HCCs, nine high-grade dysplastic nodules and their paired non-tumorous liver tissues by quantitative real-time polymerase chain reaction (qPCR) and western blot, respectively. In addition, immunochemical analysis of the BUBR1 protein was performed in 458 HCCs and 46 dysplastic nodules, and the clinicopathological significance of the BUBR1 expression was evaluated.

Results: The BUBR1 expression at both mRNA and protein levels was elevated in two of nine high-grade dysplastic nodules and in 37 of 58 (64%) HCCs. BUBR1 was overexpressed in 207 of 458 (45%) HCCs by immunohistochemistry. Intriguingly, high expression of the BUBR1 was correlated with larger tumour size, higher histological grade, advanced pathological stage, and poor overall and recurrence-free survival. There was a higher frequency of BUBR1 overexpression in cases with positive serum HBsAg than those with negative HBsAg. Moreover, BUBR1 overexpression was associated with P53 staining and high Ki67 labelling indices in HCC tissues.

Conclusions: BUBR1 was overexpressed in about 45% HCCs, and its overexpression may be a relative lately event in HCC progression. Overexpression of BUBR1 was associated with worse prognosis and is a potential prognostic factor for patients with HCC.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs